Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

The transcription factor ETS-1: its role in tumour development and strategies for its inhibition.

Hahne JC, Okuducu AF, Sahin A, Fafeur V, Kiriakidis S, Wernert N.

Mini Rev Med Chem. 2008 Oct;8(11):1095-105. Review.

PMID:
18855726
2.

ETS transcription factors: possible targets for cancer therapy.

Oikawa T.

Cancer Sci. 2004 Aug;95(8):626-33. Review.

3.

ETS transcription factors and prostate cancer: the role of the family prototype ETS-1 (review).

Shaikhibrahim Z, Wernert N.

Int J Oncol. 2012 Jun;40(6):1748-54. doi: 10.3892/ijo.2012.1380. Epub 2012 Feb 21. Review.

PMID:
22366814
4.

Differential expression of ETS family members in prostate cancer tissues and androgen-sensitive and insensitive prostate cancer cell lines.

Shaikhibrahim Z, Lindstrot A, Langer B, Buettner R, Wernert N.

Int J Mol Med. 2011 Jul;28(1):89-93. doi: 10.3892/ijmm.2011.672. Epub 2011 Apr 13.

PMID:
21491078
5.

Regulation of protein tyrosine kinases in tumour cells by the transcription factor Ets-1.

Hahne JC, Kummer S, Heukamp LC, Fuchs T, Gun M, Langer B, Von Ruecker A, Wernert N.

Int J Oncol. 2009 Nov;35(5):989-96.

PMID:
19787252
6.

Molecular mechanisms of ETS transcription factor-mediated tumorigenesis.

Kar A, Gutierrez-Hartmann A.

Crit Rev Biochem Mol Biol. 2013 Nov-Dec;48(6):522-43. doi: 10.3109/10409238.2013.838202. Epub 2013 Sep 25. Review.

7.

Comprehensive gene expression microarray analysis of Ets-1 blockade in PC3 prostate cancer cells and correlations with prostate cancer tissues: Insights into genes involved in the metastatic cascade.

Shaikhibrahim Z, Lindstrot A, Langer B, Buettner R, Wernert N.

Int J Mol Med. 2011 Jun;27(6):811-9. doi: 10.3892/ijmm.2011.652. Epub 2011 Mar 21.

PMID:
21424114
8.

Dominant-negative inhibition of Ets 1 suppresses tumor growth, invasion and migration in rat C6 glioma cells and reveals differentially expressed Ets 1 target genes.

Sahin A, Vercamer C, Kaminski A, Fuchs T, Florin A, Hahne JC, Mattot V, Pourtier-Manzanedo A, Pietsch T, Fafeur V, Wernert N.

Int J Oncol. 2009 Feb;34(2):377-89.

PMID:
19148472
9.
10.

Identification of ETS-1 target genes in human fibroblasts.

Hahne JC, Okuducu AF, Fuchs T, Florin A, Wernert N.

Int J Oncol. 2011 Jun;38(6):1645-52. doi: 10.3892/ijo.2011.981. Epub 2011 Mar 21.

PMID:
21424123
11.
12.

ETS-1 oncogenic activity mediated by transforming growth factor alpha.

Holterman CE, Franovic A, Payette J, Lee S.

Cancer Res. 2010 Jan 15;70(2):730-40. doi: 10.1158/0008-5472.CAN-09-2090. Epub 2010 Jan 12.

13.

The Ets-1 transcription factor is involved in pterygial angiogenesis.

Naib-Majani W, Breipohl W, Shazli EE, Theuerkauf I, Pleyer U, Hahne JC, Wernert N.

Anat Histol Embryol. 2007 Apr;36(2):107-10.

PMID:
17371382
14.

Understanding the role of ETS-mediated gene regulation in complex biological processes.

Findlay VJ, LaRue AC, Turner DP, Watson PM, Watson DK.

Adv Cancer Res. 2013;119:1-61. doi: 10.1016/B978-0-12-407190-2.00001-0. Review.

PMID:
23870508
15.

Defining ETS transcription regulatory networks and their contribution to breast cancer progression.

Turner DP, Findlay VJ, Moussa O, Watson DK.

J Cell Biochem. 2007 Oct 15;102(3):549-59. Review.

PMID:
17661355
16.

ETS-1 Induces Endothelial-Like Differentiation and Promotes Metastasis in Non-Small Cell Lung Cancer.

Zhou X, Zhou R, Zhou H, Li Q, Hong J, Meng R, Zhu F, Zhang S, Dai X, Peng G, Wu G, Li Z.

Cell Physiol Biochem. 2018;45(5):1827-1839. doi: 10.1159/000487874. Epub 2018 Feb 28.

17.

STAT1 and Nmi are downstream targets of Ets-1 transcription factor in MCF-7 human breast cancer cell.

Jung HH, Lee J, Kim JH, Ryu KJ, Kang SA, Park C, Sung K, Nam DH, Kang WK, Park K, Im YH.

FEBS Lett. 2005 Jul 18;579(18):3941-6.

18.
19.

Ets-1 regulates its target genes mainly by DNA methylation in human ovarian cancer.

Wan SM, Peng P, Guan T.

J Obstet Gynaecol. 2013 Nov;33(8):877-81. doi: 10.3109/01443615.2013.820268.

PMID:
24219734
20.

Caspase cleavage of Ets-1 p51 generates fragments with transcriptional dominant-negative function.

Choul-Li S, Leroy C, Leprivier G, Laitem C, Tulasne D, Aumercier M.

Biochem J. 2010 Feb 9;426(2):229-41. doi: 10.1042/BJ20090877.

PMID:
20001963

Supplemental Content

Support Center